PATENT CLAIM ANALYSIS

Application Number: 16314748
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["549", "264000"]

Abstract:
The present invention relates to the field of pharmaceuticals, especially to the field of veterinary drugs, and more particularly to a crystal form of milbemycin A3 oxime, able to be characterized by the X-ray powder diffraction spectrogram, infrared absorption (IR) spectrogram, differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA), etc. Furthermore, the present invention also relates to a method for preparing the crystal form of milbemycin A3 oxime and to a use of the crystal form of milbemycin A3 oxime as an insecticidal and acaricidal agent.

Claim (Index 10):
The method according to  claim 3 , wherein the vacuum drying temperature in step (3) is controlled to be 50\u00b0 C. to 80\u00b0 C., preferably 60\u00b0 C. to 70\u00b0 C., and the drying time is controlled to be 24-60 h, preferably 36-48 h.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.85455
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15239819', '15562155', '15562187', '13001715', '14254747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6774718278844452
- 35 USC 102 Novelty (BERT): 0.5201760654268813
- Combined Prediction Score: 0.6617422516386888
- Mean Citation Score: 189.245144
- Max Citation Score: 226.12782
- Similarity Product: 128.81596226147175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test